Abstract

The present invention relates to the pharmaceutical and nutraceutical fields and, more specifically, to a composition comprising an extract from a combination of plants for the prevention and/or treatment of a neurodegenerative disease

IPC Classes  ?

• A61K 36/61 - Myrtaceae (Myrtle family), e.g. teatree or eucalyptus
• A61K 36/28 - Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
• A61K 36/324 - Boswellia, e.g. frankincense
• A61K 36/54 - Lauraceae (Laurel family), e.g. cinnamon or sassafras
• A61K 36/835 - Aquilaria
• A61K 36/8905 - Cyperus (flatsedge)
• A61P 25/28 - Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Goods & Services

Chemical food additives; chemical seasonings (for use in the food industry); chemical food preservatives; chemical substances used as food ingredients; plant extracts for the food industry. Food supplements and dietetic preparations; nutraceutical preparations for therapeutic or medical use; nutraceutical products used as dietary supplements; nutraceuticals for humans; bark extracts for nutraceutical use; food supplements with cosmetic effect; dietary supplement beverage mixes.

Abstract

The present invention relates to the pharmaceutical and nutraceutical fields and, more specifically, to a composition comprising an extract from a combination of plants for the prevention and/or treatment of a neurodegenerative disease

IPC Classes  ?

• A61K 36/61 - Myrtaceae (Myrtle family), e.g. teatree or eucalyptus
• A61P 25/28 - Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
• A23L 33/105 - Plant extracts, their artificial duplicates or their derivatives
• A61K 9/00 - Medicinal preparations characterised by special physical form
• A61K 31/202 - Carboxylic acids, e.g. valproic acid having a carboxyl group bound to an acyclic chain of seven or more carbon atoms, e.g. stearic, palmitic or arachidic acid having three or more double bonds, e.g. linolenic acid
• A61K 36/185 - Magnoliopsida (dicotyledons)
• A61K 36/285 - Aucklandia
• A61K 36/324 - Boswellia, e.g. frankincense
• A61K 36/54 - Lauraceae (Laurel family), e.g. cinnamon or sassafras
• A61K 36/835 - Aquilaria
• A61K 36/8905 - Cyperus (flatsedge)
• A61K 36/28 - Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea

Goods & Services

Chemical additives for food; Chemical seasonings [for food manufacture]; Food preservative compositions; Chemical substances for use as food ingredients; Plant extracts for use in the manufacture of food. Dietary supplements and dietetic preparations; Nutraceutical preparations for therapeutic or medical purposes; Nutraceuticals for use as a dietary supplement; Nutraceuticals for human beings; Bark extract for nutraceutical use; Dietary supplements with a cosmetic effect; Drink mixes, for use in the following fields: Food supplements.

Goods & Services

Chemical food additives for use in the manufacture of food; plant extracts for the food industry Food supplements and dietetic preparations adapted for medical purposes; nutraceutical preparations for therapeutic and medical use; nutraceutical preparations used as dietary supplements; nutraceuticals for use as a dietary supplement for humans; bark extracts containing sandalwood bark and eaglewood bark for nutraceutical use; dietary food supplements with cosmetic effect; dietary supplement beverage mixes for human consumption in liquid and dry mix form for therapeutic purposes